61
Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease
Condition(s):Cutaneous T-Cell Lymphoma, Unspecified; Chronic Graft Versus Host Disease in SkinLast Updated:January 13, 2023Completed
Photosensitizing Agents: 643 Clinical Trials, Page 7 of 65
Hide Studies Not Open or Pending
62
Evaluation of Antimicrobial Photodynamic Therapy in Multiple Applications as a Coadjuvant in the Surgical Therapy of Access to Scaling
Condition(s):Chronic PeriodontitisLast Updated:April 13, 2018Completed
63
Randomized Study of Photodynamic Therapy Using Dihematoporphyrin in Patients With Corneal Neovascularization
Condition(s):Corneal NeovascularizationLast Updated:March 25, 2015Completed
64
Effect of Photodynamic Therapy on Skin Microbiome. Single Center Study (PHOMIC-III)
Condition(s):Prosthesis and Implants; Surgical Site Infection; Prosthetic Joint Infection; Postoperative Wound Infection Deep Incisional Surgical SiteLast Updated:January 9, 2023Not yet recruiting
65
Daylight Photodynamic Therapy for Actinic Keratosis
Condition(s):Actinic KeratosesLast Updated:March 9, 2022Completed
66
The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Aggressive Periodontitis
Condition(s):L-PRF; Photodynamic Therapy; Aggressive PeriodontitisLast Updated:September 14, 2021Not yet recruiting
67
Endobronchial Ultrasound Guided Interstitial Photodynamic Therapy in Treating Patients With Locally Advanced Lung Cancer
Condition(s):Locally Advanced Lung Carcinoma; Non-Small Cell Lung Carcinoma; Small Cell Lung Carcinoma; Stage III Lung Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8Last Updated:June 1, 2022Recruiting
68
Treatment of Intrabony Defects With Simvastatin and Antimicrobial Photodynamic Therapy
Condition(s):Simvastatin; Photodynamic Therapy; Periodontal DiseasesLast Updated:September 2, 2021Not yet recruiting
69
Photodynamic Therapy During Surgery in Treating Patients With Pleural Malignancy
Condition(s):Stage III Malignant Mesothelioma; Stage IIIB Non-small Cell Lung Cancer; Stage IV Malignant Mesothelioma; Stage IV Non-small Cell Lung CancerLast Updated:March 21, 2019Withdrawn
70
HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
Condition(s):Solid TumorLast Updated:December 20, 2022Withdrawn